📈 MD Price Movement Analysis Report for Retail Investors
🏢 Company Overview
Pediatrix Medical Group, Inc. | Sector: Healthcare | Industry: Medical – Care Facilities
This report provides a simplified overview of the adaptive price movement analysis for MD. Using historical price data up to 2025-12-01, it identifies stock-specific trading zones based on distances from 1-month highs, tailored to MD’s unique behavior. The analysis accounts for volatility relative to the S&P 500, recent price patterns, and broader market trends. This is not financial advice—always conduct your own research and consult a professional advisor. Past performance does not guarantee future results.
📊 Key Data Points
- Symbol: MD
- Analysis Date: 2025-12-01
- Current Price: $24.09
- 1-Month High: $24.99 (reached on 2025-11-28 00:00:00)
- Distance from High: 3.6%
📈 Price Trajectory (Multi-Timeframe Analysis)
- Short-term (5 days): Mild rally (+4.3% in 5 days)
- Medium-term (3 months): Strong uptrend (+41.1% in 3 months)
- Long-term (12 months): Bull market (+63.3% in 12 months)
Interpretation: The short-term shows immediate momentum from 2025-11-21 00:00:00 to 2025-12-01, while medium and long-term trends reveal the broader price structure. Current overall direction: FALLING_FROM_HIGH at NORMAL pace.
📊 RSI Momentum Indicator (RFC-008 Phase 2)
The Relative Strength Index (RSI) measures momentum on a 0-100 scale using 14-period Wilder’s smoothing. Values above 70 indicate overbought conditions (potential pullback), while values below 30 suggest oversold conditions (potential bounce).
Current RSI Status
🔴 Overbought Condition
| Metric | Value | Interpretation |
|---|---|---|
| RSI (14-day) | 75.2 | Overbought |
| Signal | 🔴 Overbought | RSI at 75.2 indicates overbought conditions – extended rally, potential pullback |
Trading Implication: RSI above 70 suggests MD may be overbought and vulnerable to pullback. Strong trends can remain overbought for extended periods. Consider:
– Taking partial profits if holding positions
– Tightening stop losses to protect gains
– Waiting for pullback to support before adding
⚠️ Caution: Overbought in uptrend can signal strength – don’t short blindly.
Methodology: Classic Wilder’s smoothing algorithm – first period uses simple average of 14-day gains/losses, subsequent periods apply exponential smoothing (prior_avg × 13 + current) / 14 for momentum continuity.
⏱️ Microstructure Timing Signals (Last 10 Candles)
⚠️ Confluence Score: 2/4 (moderate_microstructure_edge)
| Signal | Status | Value |
|---|---|---|
| 🔵 Range Compression | Normal | 0.000 |
| 🔵 Volume Activity | Normal | 0.000 |
| 🔵 Wick Patterns | 5 upper rejections vs 0 lower absorptions – selling pressure at highs | 5 rejections / 0 absorptions |
| 🔵 Candlestick Patterns | Pattern cluster: multiple shooting stars (bearish reversal), indecision patterns (doji/spinning tops) | 5 patterns |
Battle Dynamics: Sellers are defending highs aggressively (5 rejection events vs 0 absorptions). Wick strength favors bears (1.03 vs 0.00). Candlestick patterns support bearish bias.
Timing: Moderate edge present. Monitor for additional signal convergence before acting (3-7 days).
Pattern Formation Timeline
Candlestick Patterns Detected:
– 🔴 Shooting Star: Nov 17, Nov 18, Nov 20 (bearish reversal signals)
– ⚪ Doji: Nov 17 (indecision)
– 🔵 Spinning Top: Nov 21 (indecision)
Wick Events:
– ⬆️ Upper Rejections: Nov 17, Nov 18, Nov 20, Nov 21, Nov 26 (selling pressure)
Microstructure analysis examines the last 10 candles for timing signals.
📉 Volatility and Market Context
MD’s price movements are classified as “Very High (Small-caps, biotech)” with an annualized volatility of 46.5% and a typical daily price swing of 2.93% ($0.71). This means MD can move about 2.93% daily, which is high compared to other stocks.
- 🎯 Relative Volatility: MD’s current volatility ranks in the 93.0th percentile compared to the historical volatility of the S&P 500 (SPY). This means MD’s price swings are larger than those of the broader market on 93.0% of historical trading days, indicating higher risk than the market.
- 🌍 Market Environment: The analysis identifies a neutral market, with the S&P 500 (SPY) trading at $683.39, 1.9% above its 50-day moving average ($670.44). Bear markets increase selling pressure, requiring wider safety margins.
| Metric | Value | Explanation |
|---|---|---|
| 📊 Stock Volatility | 46.5% (annualized) | Yearly price fluctuations; higher means more risk/reward |
| 📅 Daily Movement | 2.93% ($0.71) | Typical daily price change for stop-loss levels |
| 🎯 Volatility vs. SPY | 93.0th percentile | higher risk than the market |
| 📈 Market Trend | neutral (1.9% vs. SMA50) | Challenging market conditions; zones are wider to account for higher risk. |
🎯 Price-Based Trading Zones
This analysis uses MD’s historical price patterns to define trading zones based on percentage distances from its 1-month high ($24.99). These zones are adjusted for MD’s high volatility (widened for larger swings), recent price behavior (emphasizing data from the last ~3.4 years), and the neutral market environment (wider near-high zones). The zones are based on 55 historical reversal points (21 resistance, 34 support), with recent patterns weighted more heavily (average weight: 0.11).
| Zone | Distance (%) | Price Level | Trading Insight |
|---|---|---|---|
| 🔴 Resistance | 1.3 | $24.67 | Avoid buying; strong selling pressure likely |
| 🟡 Caution | 3.3 | $24.17 | Reduce positions or hedge; watch for reversals |
| 🟢 Sweet Spot | 7.3 | $23.17 | Optimal buy zone with 34.0% success rate |
| 💎 Value | 11.3 | $22.17 | Attractive buy on pullback; strong bounce zone |
| 🔵 Deep Value | 16.3 | $20.92 | Potential reversal, but risky; confirm with catalysts |
| ⚠️ Extreme Value | 16.4 | $20.89 | Severe oversold; high crash risk—wait for catalyst |
| 🚨 Crash Zone | >30% | Below extreme | Critical danger zone—avoid unless deep value investor |
📈 Historical Performance: At the optimal distance (7.3% from high), MD has historically broken out (made new highs) 34.0% of the time, with a 30.0% chance of crashing (dropping 10%+). The risk/reward ratio is 1.1:1, making the sweet spot favorable.
🎯 Advanced Success Analysis (RFC-011 Phase 2)
This analysis uses two methods to measure historical success when MD was in similar price contexts:
📊 Binary Success (Traditional Method)
– What it measures: Did the stock reach NEW all-time highs?
– Rate: 55.0%
– Limitation: All-or-nothing – ignores partial progress
📈 Graded Success (Enhanced Method)
– What it measures: Progress toward the next high, with partial credit:
– 🟢 100% = Made new high (full success)
– 🟡 85% = Reached 85% of the way to new high
– 🟡 75% = Reached 75% of the way
– 🟠 50% = Reached halfway point
– 🔴 25% = Made 25% progress
– ❌ 0% = No progress or declined
– Rate: 65.0%
– Advantage: Shows favorable risk/reward even with conservative targets
| Metric | Value | Notes |
|---|---|---|
| Binary Success | 55.0% | 73 samples – moderate confidence |
| Graded Success | 65.0% | 73 samples – moderate confidence |
| Improvement | +10.0 points | Graded method captures partial gains |
📊 Confidence Breakdown (43.7/100 – Low):
– Sample Size: 40/40 points – Based on 51.5 weighted samples
– Quality: 0.8/40 points – Average similarity and recency (0.69)
– Consistency: 2.9/20 points – Low variance = predictable outcomes
🔍 Sample Quality & Reliability:
– Total Samples: 73 similar historical contexts
– Effective Samples: 51.5 (weighted by recency)
– Recent Data: 86.6% from last 3 years
– Raw Rate: 79.9% (before adjustments)
– Cap Applied: Yes (55.0% max prevents overconfidence)
📊 What This Means: The graded success rate of 65.0% vs binary 55.0% (improvement: +10.0pp) shows that even when $MD doesn’t make new highs, it often makes significant partial progress (50-85% of the way), indicating favorable risk/reward even with conservative price targets.
💰 Price Targets and Risk Management
These price levels translate the percentage zones into actionable dollar amounts, with stop-loss suggestions based on MD’s daily volatility (ATR).
| Target Type | Price Level | Notes |
|---|---|---|
| 🟢 Optimal Buy | $23.17 | Enter in sweet spot for best risk/reward. |
| 🟢 Good Value | $22.17 | Strong buy opportunity on deeper pullback. |
| 🟢 Deep Value | $20.92 | Oversold; wait for reversal signals (e.g., high volume, news). |
| 🔴 Reduce Position | $24.17 | In caution zone—scale back exposure. |
| 🔴 Exit/Hedge | $24.67 | Near resistance—consider selling or hedging. |
| 🚀 Breakout Confirmation | $25.24 | 1% above high—signals new uptrend. |
| 🚀 Strong Breakout | $25.74 | 3% above high—confirms bullish momentum. |
| 🛡️ Tight Stop | $22.33 | -$1.76 (7.3%) below current price. |
| 🛡️ Normal Stop | $20.92 | -$3.17 (13.2%) below current price. |
| 🛡️ Wide Stop | $19.5 | -$4.59 (19.1%) below current price. |
| 📊 Position Sizing | 10-25% (Sweet spot) | Low confidence due to TRANSITION_ZONE. |
⚖️ Risk/Reward Methodology (RFC-008 Phase 5)
Transparent breakdown of risk/reward calculation using current price, target price projection, and volatility-adjusted stop loss.
Risk/Reward Analysis
🔴 Quality Assessment: Poor (0.68:1)
| Component | Value | Notes |
|---|---|---|
| Entry Price | $24.09 | Current market price for MD |
| Target Price | $26.24 | Projected resistance or breakout level |
| Stop Loss | $20.92 | Risk management exit point |
| Potential Reward | $2.15 | Target – Entry |
| Potential Risk | $3.17 | Entry – Stop |
| R/R Ratio | 0.68:1 | Reward divided by Risk |
Calculation Breakdown
Formula: (Target - Entry) / (Entry - Stop)
Step-by-step:
1. Reward = $26.24 (target) – $24.09 (entry) = $2.15
2. Risk = $24.09 (entry) – $20.92 (stop) = $3.17
3. Ratio = $2.15 / $3.17 = 0.68:1
Stop Loss Determination: Normal stop level ($20.92)
14-Day ATR: $3.64 (used for volatility-adjusted stop placement)
💡 Interpretation
A ratio below 1.0:1 is poor – you’re risking more than potential reward. Avoid this trade setup unless conviction is extremely high.
Position Sizing Guidance: With a 0.68:1 R/R ratio, if you risk 1% of portfolio capital, you target 0.68% potential gain. Adjust position size so that hitting the stop loss = acceptable portfolio loss (typically 0.5-2% per trade).
Important: This R/R calculation assumes execution at entry price and hitting either target or stop. Actual results may vary with slippage, partial exits, or trailing stops.
🎯 Current Analysis
Current Position: MD is BETWEEN ZONES at $24.09 (above Sweet Spot $23.17, below Caution $24.17)
📋 Recommendation: WAIT_FOR_PULLBACK
💡 Explanation: Price in TRANSITION_ZONE with favorable historical performance (55% breakout rate). ⚠️ Confidence adjusted to LOW due to mild bearish volume divergence. Entry acceptable with reduced position size pending volume stabilization. declining from recent high. Market regime: Extreme parabolic move – historical patterns unreliable.
🔍 Confidence: LOW
📈 Historical Success: 0.65
⚖️ Risk/Reward: 3.84
📋 Trading Scenarios
Based on current price position and technical setup, here are actionable trade scenarios with defined entries, targets, and stops:
📉 Scenario A: Pullback Entry (Conservative)
Best for: Patient swing traders seeking optimal risk/reward
Entry Conditions:
– Price pulls back to $23.17 (Sweet Spot) or $22.17 (Value Zone)
– Volume decreases on pullback (no panic selling)
– ⚠️ Confirm OBV stabilizes before entry
Position Setup:
– Entry: $23.17 – $22.17
– Initial Target: $26.50 (resistance zone)
– Extended Target: $27.76 (breakout area)
– Stop Loss: $19.50 (below value zone)
– Position Size: 75-100% (high confidence zone)
Risk/Reward: ~0.8:1 to first target
Why This Works:
– Buying at historical support/value zone
– Better entry price = more cushion to downside
– Waiting for confirmation of support hold
🚀 Scenario B: Breakout Entry (Momentum)
Best for: Momentum traders wanting confirmation before entry
Entry Conditions:
– Price breaks above $25.24 (1% above high)
– Volume expands (>1.5x average) on breakout day
– Price holds above breakout level for 2+ hours (avoid false breakout)
– Verify OBV rises with breakout
Position Setup:
– Entry: $25.24 (on confirmation) or first pullback to $25.11
– Initial Target: $26.50 (5% extension)
– Extended Target: $28.27 (measured move)
– Stop Loss: $24.48 (below breakout level)
– Position Size: 50-75% (momentum play with confirmation)
Risk/Reward: ~1.6:1 to first target
Why This Works:
– Breakout confirms new uptrend beginning
– Volume expansion validates institutional participation
– Clear invalidation point (breakdown below breakout)
📊 Comprehensive Volume Analysis
Volume analysis provides institutional-level insights into supply and demand dynamics. This advanced analysis combines multiple volume indicators to identify accumulation, distribution, and potential divergences.
On-Balance Volume (OBV) – Cumulative Volume Pressure
📉 Current Trend: Down
10-Day Net Change: -2,341,037
Interpretation: Bearish – OBV declining over 10 days (-2,341,037)
OBV tracks cumulative buying and selling pressure. Rising OBV with price suggests healthy accumulation; falling OBV with rising price may indicate distribution (bearish divergence).
VWAP Multi-Timeframe Confluence
🟡 Confluence Signal: Mixed Signals
| Timeframe | Signal | Weight | Interpretation |
|---|---|---|---|
| 5-Day | Neutral | High | Immediate institutional positioning |
| 14-Day | Neutral | Medium | Swing accumulation/distribution |
| 30-Day | Neutral | Medium | Trend-level volume commitment |
VWAP (Volume-Weighted Average Price) represents the average price paid by institutions. Price above VWAP with accumulation suggests bullish control; below VWAP with distribution indicates bearish pressure.
Volume Activity Metrics
⬇️ Relative Volume: 0.64x
vs. 20-Day Average: -35.8%
Recent Volume Spikes: 0 in last 30 days
Quality Ratio: 1.01 (Accumulation)
ℹ️ Volume-Price Divergence Analysis
Severity: Mild
Type: Bearish (confidence -5%)
Signals:
– ⚠️ Volume-price divergence: Rising price not confirmed by volume
Divergences between price and volume can signal potential reversals or continuations. Monitor closely for confirmation.
💡 Volume Integration with Price Zones
Combining volume analysis with price-based zones enhances decision accuracy:
– Near Resistance + Distribution: High risk—institutions may be selling into strength
– Value Zone + Accumulation: Strong buy signal—institutions building positions
– Breakout + High Volume: Confirms new trend—likely to sustain
– Price Divergence + Volume Divergence: Critical warning—potential reversal imminent
Use volume to validate price zone recommendations and improve entry/exit timing.
📊 Moving Average Cluster Analysis
Current MA Positioning
| MA Period | Price | Distance | Slope | Direction | Support Quality |
|---|---|---|---|---|---|
| SMA10 | $23.49 | -2.5% | +3.38% | 📈 Rising | Strong |
| SMA20 | $22.52 | -6.5% | +7.64% | 📈 Rising | Strong |
| SMA50 | $19.10 | -20.7% | +4.14% | 📈 Rising | Strong |
| SMA200 | $15.50 | -35.7% | +1.64% | 📈 Rising | Strong |
🎯 Detected MA Clusters
No significant MA clusters detected. Moving averages are well-distributed, suggesting clear individual support/resistance levels rather than convergence zones.
🎚️ Prioritized Pullback Targets
1️⃣ Primary Target: $23.49 (2.5% pullback)
- MA Level: SMA10
- Probability: HIGH (Priority Score: 135/100)
- MA Characteristics: SMA10 support – rising strong
- Risk/Reward: Excellent support likely, minimal pullback distance
- What to Watch: Price action at this level, volume decrease on approach
2️⃣ Secondary Target: $22.52 (6.5% pullback)
- MA Level: SMA20
- Probability: HIGH (Priority Score: 125/100)
- MA Characteristics: SMA20 support – rising strong
- Risk/Reward: Excellent support likely, minimal pullback distance
- What to Watch: Major trend reversal signal if tested, significantly increased volume
3️⃣ Tertiary #1 Target: $19.10 (20.7% pullback)
- MA Level: SMA50
- Probability: HIGH (Priority Score: 105/100)
- MA Characteristics: SMA50 support – rising strong
- Risk/Reward: Excellent support likely, minimal pullback distance
- What to Watch: Major trend reversal signal if tested, significantly increased volume
4️⃣ Tertiary #2 Target: $15.50 (35.7% pullback)
- MA Level: SMA200
- Probability: MODERATE (Priority Score: 85/100)
- MA Characteristics: SMA200 support – rising strong
- Risk/Reward: Strong support likely, moderate pullback distance
- What to Watch: Major trend reversal signal if tested, significantly increased volume
💡 Trading Recommendation
Action: Watch For Pullback
Confidence: HIGH
Primary Entry: $23.49 (UNKNOWN support)
Secondary Entry: $22.52 (UNKNOWN support)
Entry Strategy:
Watch for price action at $23.49 (-2.5% from current). Look for bullish reversal candle (hammer, bullish engulfing, etc.).
Risk Management:
– Stop loss below primary target (suggest $23.02 range)
– Risk/Reward: Risk assessment unavailable
Confirmation Signals:
– Decreasing volume on pullback
– Bullish reversal candlestick at support level
– RSI oversold condition (<40)
– Higher volume on bounce
🔄 Peer Momentum Comparison (RFC-008)
Understanding relative performance vs. sector peers clarifies whether price movement is company-specific or sector-wide.
Peers Analyzed: 5 (LLM-discovered, programmatically validated)
Target vs. Sector Performance
| Metric | MD | Sector Avg | Relative | Status |
|---|---|---|---|---|
| 5-Day Change | +4.29% | +11.44% | -7.15pp | 📉 Underperforming |
| 10-Day Change | +4.06% | +6.38% | -2.32pp | 📉 Underperforming |
Peer Momentum Breakdown
| Ticker | 5-Day | 10-Day |
|---|---|---|
| CYH | +17.69% | +3.59% |
| THC | +16.16% | +10.26% |
| AMN | +8.54% | +3.61% |
| UHS | +8.10% | +7.06% |
| HCA | +6.72% | +7.40% |
💡 Interpretation
⚠️ Company-specific weakness: MD is lagging peers, indicating potential company-level issues or missed opportunities relative to sector.
Discovery Method: LLM-driven peer identification with programmatic validation (sector match, market cap band 0.25x-4x).
The selected peers are all operating in the healthcare services sector, providing specialized healthcare services. They were chosen based on their similar business models, revenue mix, and factor exposures to Pediatrix Medical Group, Inc.
💼 Investment Considerations
- 🏦 Long-Term Investors: Consider entry points near $22.17 (value zone) to $20.92 (deep value) with wide stops ($19.5) to manage downside. Current price at $24.09 is 3.6% below high. Monitor upcoming earnings or sector news for catalysts.
- ⚡ Short-Term Traders: Wait for a breakout above $25.24 or a confirmed bounce in the deep value zone. Track Medical – Care Facilities sector trends.
- 🌍 Market Context: The neutral market supports potential upside, but MD’s high relative volatility (93.0th percentile) suggests bigger swings—diversify and stay cautious.
🔬 Methodology
This analysis uses the Adaptive Peak Distance Analyzer, a proprietary tool that studies MD’s historical price movements to identify optimal trading zones. It calculates:
– 📊 Price Zones: Based on distances from 52-week highs where MD historically breaks out or reverses, using 1254 days of data (since ~2021).
– 📈 Volatility Adjustment: Compares MD’s 30-day volatility (46.5%) to SPY’s historical distribution, ranking at the 93.0th percentile, widening zones for safety.
– ⏰ Time Decay: Weights recent price reversals (~3.4 years) more heavily (average weight: 0.11) to reflect current behavior.
– 🌍 Market Regime: Adjusts zones based on SPY’s position (1.9% vs. 50-day SMA), wider near-high zones.
– 📊 Volume Analysis: When available, integrates volume profile analysis including On-Balance Volume (OBV), Volume Weighted Average Price (VWAP), and volume-price divergence patterns to validate price movements and identify institutional accumulation/distribution.
– 📏 Metrics: Uses ATR (2.93%) for stop-losses and risk/reward ratios (1.1:1 at sweet spot).
The analysis is robust (1254 samples, “High (Robust dataset)” quality) but focuses on price patterns and volume trends, not fundamental analysis. For broader context, check financial news or analyst reports.
🏢 About Pediatrix Medical Group, Inc.
Sector: Healthcare | Industry: Medical – Care Facilities
Pediatrix Medical Group, Inc., together with its subsidiaries, provides newborn, maternal-fetal, pediatric cardiology, and other pediatric subspecialty care services in the United States and Puerto Rico. It offers neonatal care services, such as clinical care to babies born prematurely or with complications within specific units at hospitals through neonatal physician subspecialists, neonatal nurse practitioners, and other pediatric clinicians. The company also provides maternal-fetal care servi…
⚠️ Disclaimer
This report is for informational purposes only and does not constitute financial advice. Investing in stocks like MD involves risks, including loss of principal. The analysis relies on historical price data and may not predict future performance. Always conduct your own research, consider your financial situation, and consult a licensed financial advisor before making investment decisions.
Report generated on December 01, 2025
